Synapse - Larry Norton

Results (40)

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: A report of CALGB 9082, SWOG 9114, and NCIC MA-13

Journal Article

Peters, W. P.; Rosner, G. L.; Vredenburgh, J. J.; Shpall, E. J.; Crump, M.; Richardson, P. G.; Schuster, M. W.; Marks, L. B.; Cirrincione, C.; Norton, L.; more...
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Dose-dense adjuvant chemotherapy for primary breast cancer

Journal Article

Fornier, M.; Norton, L.
Breast Cancer Research (2005)

Fulltext@MSK | Save

Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients

Journal Article

Dressler, L. G.; Berry, D. A.; Broadwater, G.; Cowan, D.; Cox, K.; Griffin, S.; Miller, A.; Tse, J.; Novotny, D.; Persons, D. L.; more...
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials

Journal Article

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet (2005)

Fulltext@MSK | Save

Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary

Journal Article

Tornos, C.; Soslow, R.; Chen, S.; Akram, M.; Hummer, A. J.; Abu Rustum, N.; Norton, L.; Tan, L. K.
American Journal of Surgical Pathology (2005)

Fulltext@MSK | Save

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series

Journal Article

Robson, M.; Svahn, T.; McCormick, B.; Borgen, P.; Hudis, C. A.; Norton, L.; Offit, K.
Cancer (2005)

Fulltext@MSK | Save

Conceptual and practical implications of breast tissue geometry: Toward a more effective, less toxic therapy

Journal Article

Norton, L.
The Oncologist (2005)

Fulltext@MSK | Save

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

Journal Article

Muss, H. B.; Woolf, S.; Berry, D.; Cirrincione, C.; Weiss, R. B.; Budman, D.; Wood, W. C.; Henderson, I. C.; Hudis, C.; Winer, E.; more...
JAMA - Journal of the American Medical Association (2005)

Fulltext@MSK | Save

A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer

Journal Article

Modi, S.; Seidman, A. D.; Dickler, M.; Moasser, M.; D'Andrea, G.; Moynahan, M. E.; Menell, J.; Panageas, K. S.; Tan, L. K.; Norton, L.; more...
Breast Cancer Research and Treatment (2005)

Fulltext@MSK | Save

Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer

Journal Article

Modi, S.; DiGiovanna, M. P.; Lu, Z.; Moskowitz, C.; Panageas, K. S.; Van Poznak, C.; Hudis, C. A.; Norton, L.; Tan, L.; Stern, D. F.; more...
Cancer Investigation (2005)

Fulltext@MSK | Save